0

Global Pediatric Vaccine Market 2019-2023

  • Published: Feb 2019
  • Pages: 136
  • SKU: IRTNTR30870
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The pediatric vaccines market size will grow by USD 10.76 billion during 2019-2023. The report offers an analysis of the market based on product (conjugate vaccines and others, live-attenuated vaccines, toxoid vaccines, and inactivated vaccines). The market research report further presents in-depth insights on the growth prospects of the market across geographic regions such as Asia, Europe, North America, and ROW. The report analyzes the market’s competitive landscape and offers information on several companies including CSL Limited, GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., and Sanofi.

Below are some of the key findings from the pediatric vaccines market analysis report

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from the report.

Get a FREE sample now!  

Global Pediatric Vaccine Industry Overview

Strong late-stage pipeline and new drug approvals are critical factors that will drive the growth of the pediatric vaccines market. There is a significant number of monotherapy and combination therapy-based vaccines with high potential to prevent many allergies and infectious diseases in children. These vaccines are in the last stages of development, and their potential can be determined through the results of clinical trials. As a result, they have high chances of getting approved and entering the market for pediatric health in the forthcoming years, thus improving the vaccination rate. Furthermore, the recently approved vaccines for pediatric health are also driving the market growth. 

Vaccines are the most effective medical intervention that provides promising results for the reduction of mortality rates. There are several unmet medical conditions such as tuberculosis, Ebola, cancer, HIV, malaria, dengue, H1N1, H5N1, and allergic conditions. The growing focus on the development of vaccines for these unmet medical conditions will further promote vaccination for pediatric health. This will drive the pediatric vaccines market to grow at a CAGR of over 7% during the forecast period. The leading manufacturers are using nucleic acids, vectors, structure-based antigen design, and adjuvants to develop novel pediatric vaccines. This is made possible through significant advancements in computational biology and molecular biology.

Top companies covered in the pediatric vaccines market research report

The pediatric vaccines market is moderately concentrated. To help clients improve their market position, the report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies. Moreover, the market analysis report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make most of the upcoming growth opportunities.

The report offers a detailed analysis of several leading pediatric vaccine companies, including:

  • CSL Limited
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi

Pediatric vaccines market segmentation based on geographic regions

  • Asia
  • Europe
  • North America
  • ROW

North America will hold the highest market share of the market throughout the forecast period. The growing incidence of infectious diseases, availability of reimbursement schemes, government initiatives, and new vaccine approvals are some of the primary reasons for the high growth of the pediatric vaccines market in the region.

Pediatric vaccines market segmentation based on product

  • Conjugate vaccines and others
  • Live-attenuated vaccines
  • Toxoid vaccines
  • Inactivated vaccines

The conjugate vaccines and others market segment will account for the highest share of the pediatric vaccines market as vaccines under the segment are the most advanced in terms of composition as well as the immune response they generate in the body. The increasing use of conjugate vaccines for children, rising number of regulatory approvals for conjugate vaccines, and prevalence of infectious diseases are the major drivers for the growth of the segment. The report provides an accurate prediction of the contribution of all the segments to the growth of the pediatric vaccines market size.

Key highlights of the global pediatric vaccines market for the forecast years 2019-2023:

  • CAGR of the market during the forecast period 2019-2023
  • Detailed information on factors that will accelerate the growth of the pediatric vaccines market during the next five years
  • Precise estimation of the global pediatric vaccines market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the industry across various geographies such as Asia, Europe, North America, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on several vendors
  • Comprehensive details on factors that will challenge the growth of the companies

We can help! Our analysts can customize the market research report to meet your requirements. Get in touch

 

Read More Read Less

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: PIPELINE ANALYSIS

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Conjugate vaccines and others - Market size and forecast 2018-2023
  • Live-attenuated vaccines - Market size and forecast 2018-2023
  • Toxoid vaccines - Market size and forecast 2018-2023
  • Inactivated vaccines - Market size and forecast 2018-2023
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY TYPE

  • Monovalent vaccines
  • Multivalent vaccines

PART 10: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • CSL Limited
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi

PART 15: APPENDIX

  • Research methodology
  • List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Reports 2019
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>